Form 4 for IRMD IRADIMED CORP
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-21 · accession 0000898432-23-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-02-22 | 2023-02-21 | IRMD | Susi Roger E. | Pres, CEO, COB, Dir, 10% | S - Sale | $36.75 | -10.0K | 603.0K | -2% | -$367.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | S | D | 10,000 | $36.75 | 602,950 | I By Roger E. Susi Revocable Trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $36.37 to $37.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |